# Current Trends and Future Perspectives of Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome: A Narrative Review

**Authors:** Toru Maruyama, Michinari Hieda, Mitsuhiro Fukata

PMC · DOI: 10.7759/cureus.104731 · Cureus · 2026-03-05

## TL;DR

BRASH syndrome is a dangerous condition in elderly patients involving heart and kidney issues, often triggered by medications or infections like COVID-19.

## Contribution

This review highlights BRASH syndrome's relevance in geriatric emergency medicine, especially in the context of heart failure and post-COVID-19 care.

## Key findings

- BRASH syndrome is common in elderly patients with hypertension or chronic kidney disease.
- Two cases were linked to COVID-19 as a trigger.
- Common comorbidities include hypertension, chronic kidney disease, and diabetes.

## Abstract

BRASH syndrome is defined as a clinical condition in which bradycardia, renal failure, atrioventricular (AV) nodal blockade, shock, and hyperkalemia interact to form a self-perpetuating negative spiral. Geriatric practitioners are increasingly likely to encounter elderly patients with this syndrome who are taking AV nodal blocking agents, such as calcium channel blockers (CCBs) or β-blockers. However, it remains unclear how the heart failure (HF) pandemic and coronavirus disease 2019 (COVID-19) have influenced the incidence, triggers, management, and clinical course of BRASH syndrome. Therefore, open-access databases were searched for publications from 1980 to 2025, identifying 41 eligible articles reporting a total of 54 patients with BRASH syndrome. The mean age of affected patients was 69.0 ± 15.1 years. Hypertension (HTN, 74%), chronic kidney disease (CKD, 61%), and diabetes (54%) were the most common comorbidities. More than half of the patients (52%) were prescribed angiotensin-suppressing agents (angiotensin-converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARB), or angiotensin receptor-neprilysin inhibitors (ARNI)) for HTN or HF. Two elderly patients were diagnosed with BRASH syndrome triggered by COVID-19. This literature review clarifies that BRASH syndrome commonly occurs in elderly patients with HTN or CKD and is often associated with everyday clinical events such as anorexia, vomiting, diarrhea, bleeding, and infection, including COVID-19. Our database search supports recognizing BRASH syndrome as an important clinical entity in geriatric emergency medicine. Geriatric practitioners should be aware of this condition to enable early diagnosis and appropriate management in the modern HF and post-COVID-19 era.

## Linked entities

- **Diseases:** heart failure (MONDO:0005252), coronavirus disease 2019 (MONDO:0100096), chronic kidney disease (MONDO:0005300), diabetes (MONDO:0005015)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, SGCB (sarcoglycan beta) [NCBI Gene 6443] {aka A3b, LGMD2E, LGMDR4, SGC}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** DL (MESH:C537113), anorexia (MESH:D000855), DM (MESH:D009223), CKD (MESH:D051436), cancer (MESH:D009369), diabetes (MESH:D003920), HD (MESH:D006816), BRASH (MESH:D051437), acute coronary syndrome (MESH:D054058), dyslipidemia (MESH:D050171), Hyperkalemia (MESH:D006947), sinus bradycardia (MESH:D012804), cirrhosis (MESH:D005355), Inflammatory (MESH:D007249), shock (MESH:D012769), vomiting (MESH:D014839), hypoxemia (MESH:D000860), systemic diseases (MESH:D034721), Bradyarrhythmias (MESH:D001919), Fever (MESH:D005334), cardiac drug toxicity (MESH:D066126), Hypotension (MESH:D007022), acute kidney injury (MESH:D058186), diarrhea (MESH:D003967), myocarditis (MESH:D009205), bleeding (MESH:D006470), febrile (MESH:D000071072), multi-organ failure (MESH:D009102), acute respiratory failure (MESH:D012131), acidosis (MESH:D000138), AV block (MESH:D054537), hypovolemia (MESH:D020896), cytotoxic (MESH:D064420), cough (MESH:D003371), AV nodal blockade (MESH:D013611), dehydration (MESH:D003681), AF (MESH:D001281), COVID-19 (MESH:D000086382), chronic renal failure (MESH:D007676), dilated cardiomyopathy (MESH:D002311), infection (MESH:D007239), myocardial infarction (MESH:D009203), sinus arrest (MESH:D054138), HTN (MESH:D006973), sepsis (MESH:D018805), cardiac remodeling (MESH:D020257), hypokalemia (MESH:D007008), renal impairment (MESH:D007674), HF (MESH:D006333)
- **Chemicals:** epinephrine (MESH:D004837), remdesivir (MESH:C000606551), aldosterone (MESH:D000450), felodipine (MESH:D015736), carvedilol (MESH:D000077261), nifedipine (MESH:D009543), Tolvaptan (MESH:D000077602), albuterol (MESH:D000420), cGMP (MESH:D006152), dihydropyridine (MESH:C038806), NO (MESH:D009569), atropine (MESH:D001285), Ivabradine (MESH:D000077550), water (MESH:D014867), aspirin (MESH:D001241), propranolol (MESH:D011433), Cr (MESH:D002857), K (MESH:D011188), bisoprolol (MESH:D017298), flecainide (MESH:D005424), ARNI (-), Ca (MESH:D002118), nitrendipine (MESH:D009568), creatinine (MESH:D003404), amlodipine (MESH:D017311), verapamil (MESH:D014700), Vericiguat (MESH:C000603960), ranolazine (MESH:D000069458), amiodarone (MESH:D000638)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12966773/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12966773/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC12966773/full.md

---
Source: https://tomesphere.com/paper/PMC12966773